Showing 11-20 of 24 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Investigating the association between environmental contaminants and progression to autoimmune disease | Regents of the University of Colorado | Jill Norris | Cures | 01-September-2026 to 31-August-2027 | $149.999,97 |
| Islet autoantibody concordance and metabolic monitoring of individuals identified at risk for type 1 diabetes through population-based screening | Regents of the University of Colorado | Kimber Simmons | Cures | 01-July-2023 to 31-December-2026 | $750.000,00 |
| Innovating Methods for AssessinG INsulin Action in Type ONe diabetes (IMAGINATiON) | Regents of the University of Colorado | Kristen Nadeau | Improving Lives | 01-December-2021 to 31-December-2026 | $445.816,29 |
| Validation of Enzyme-linked immunosorbent assay (ELISA) to detect insulin autoantibodies | Regents of the University of Colorado | Liping Yu | Cures | 01-June-2025 to 31-May-2027 | $453.852,00 |
| Antigenic Targets of CD4 T cells across the stages of type 1 diabetes | Regents of the University of Colorado | Maki Nakayama | Cures | 01-August-2022 to 31-July-2026 | $749.998,87 |
| Autoimmunity Screening for Kids (ASK) | Regents of the University of Colorado | Marian Rewers | Cures | 01-November-2024 to 31-October-2027 | $3.074.807,75 |
| Immunogenicity of workload-regulated beta cell states in type 1 diabetes | Regents of the University of Colorado | Matthew Wortham | Cures | 01-August-2026 to 31-July-2031 | $1.000.000,00 |
| Mechanisms of B Cell Polyreactivity in Autoimmunity: Toward Precision Immunotherapy | Regents of the University of Colorado | Mia Smith | Cures | 01-September-2025 to 31-January-2027 | $149.965,60 |
| Improving the Uptake and Applicability of the Clinical and Economic Optimization Platform for Type 1 Diabetes Screening | Regents of the University of Colorado | R. Brett McQueen | Cures | 01-September-2024 to 31-August-2027 | $451.890,07 |
| Contrast enhanced ultrasound imaging to track type 1 diabetes progression in at-risk pediatric subjects | Regents of the University of Colorado | Richard Benninger | Cures | 01-August-2026 to 31-July-2029 | $707.121,00 |